David J. Endicott's Net Worth
$11.5 Million
Who is David J. Endicott?
David J. Endicott has an estimated net worth of $11.5 Million. This is based on reported shares across multiple companies, which include Zeltiq Aesthetics Inc, Orexigen Therapeutics, Inc., ALLERGAN INC, and HOSPIRA INC.
SEC CIK
David J. Endicott's CIK is 0001532133
Past Insider Trading and Trends
2012 was David J. Endicott's most active year for acquiring shares with 8 total transactions. David J. Endicott's most active month to acquire stocks was the month of January. 2012 was David J. Endicott's most active year for disposing of shares, totalling 11 transactions. David J. Endicott's most active month to dispose stocks was the month of October. 2015 saw David J. Endicott paying a total of $6,638,482.71 for 178,167 shares, this is the most they've acquired in one year. In 2015 David J. Endicott cashed out on 278,639 shares for a total of $18,510,120.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Zeltiq Aesthetics Inc No price found
InvestorDavid J. Endicott used to own units in Common Stock but no longer holds any shares there. In the year 2016 David J. Endicott filed a total of 4 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -16.13K |
—
|
—
|
0
|
Apr 28
| |||
Form 4
| +62.41% | 6.2K |
$28.23 | $174,997.77 | 16.13K |
Jun 16
| |||
Form 4
|
∞
| 9.93K |
—
|
—
| 9.93K |
Apr 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Orexigen Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALLERGAN INC No price found
CVP and President, AGN MedDavid J. Endicott owns 17,335 units of Common Stock.acquired a total of 82,378 shares in ALLERGAN INC at a cost of $4,855,140.00, David also disposed a total of 85,231 shares of ALLERGAN INC equalling to $7,961,619.89.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -13.88% | -2.79K |
$108.08 | -$301,975.52 | 17.34K |
Feb 20 - Feb 21
| |||
Form 4
| -1.11% | -225.00 |
$108.02 | -$24,304.50 | 20.13K |
Feb 15
| |||
Form 4/A
|
—
|
0
|
$78.40 | -$54,042.95 | 20.35K |
Nov 29
| |||
Form 4
|
—
|
0
|
$78.45 | -$1,469,430.43 | 20.35K |
Nov 29
| |||
Form 4
|
—
|
0
|
$71.30 | -$1,238,225.25 | 20.35K |
May 7
| |||
Form 4
| -1.03% | -212.00 |
$87.27 | -$18,501.24 | 20.35K |
Feb 22
| |||
Form 4
| +1.87% | 378 |
—
|
—
| 20.56K |
Feb 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HOSPIRA INC No price found
Pres., Hospira Medical DevicesDavid J. Endicott used to own units in Common Stock but no longer holds any shares there. In the year 2014 David J. Endicott acquired a total of 205,668 shares in HOSPIRA INC at a cost of $9,971,800.72, David also disposed a total of 205,668 shares of HOSPIRA INC equalling to $18,510,120.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -117.50K |
$66.51 | -$15,371,637.29 |
0
|
Sep 3
| |||
Form 4
| +51.61% | 40K |
$87.50 | $3,500,000.00 | 117.5K |
Feb 25
| |||
Form 4
|
∞
| 77.5K |
$43.01 | $3,333,318.01 | 77.5K |
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||